We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

21 hedge funds and large institutions have $4.59M invested in Alimera Sciences in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 22 → 21 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

60% less capital invested

Capital invested by funds: $11.4M → $4.59M (-$6.83M)

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
7
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DMK
David M. Knott
+$183K
2
WVP
Worth Venture Partners
New Jersey
+$170K
3
RA
Royce & Associates
New York
+$91.3K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$18.7K
5
Victory Capital Management
Victory Capital Management
Texas
+$7.75K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.58M
2
BFM
Boothbay Fund Management
New York
-$566K
3
TRCT
Tower Research Capital (TRC)
New York
-$13.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
1
Avoro Capital Advisors
New York
$1.6M – – –
PAI
2
Palo Alto Investors
California
$804K – – –
WVP
3
Worth Venture Partners
New Jersey
$509K +$170K +28,000 +28%
Vanguard Group
4
Vanguard Group
Pennsylvania
$474K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$304K +$1.83K +300 +0.4%
DMK
6
David M. Knott
$301K +$183K +30,039 +67%
RA
7
Royce & Associates
New York
$235K +$91.3K +15,000 +33%
JAM
8
JW Asset Management
Florida
$110K – – –
BCM
9
Bridgeway Capital Management
Texas
$100K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$51K +$18.7K +3,078 +30%
Morgan Stanley
11
Morgan Stanley
New York
$42K +$1.47K +242 +2%
BlackRock
12
BlackRock
New York
$42K +$3.47K +570 +6%
Deutsche Bank
13
Deutsche Bank
Germany
$11K – – –
Victory Capital Management
14
Victory Capital Management
Texas
$6K +$7.75K +1,274 New
TRCT
15
Tower Research Capital (TRC)
New York
$2K -$13.5K -2,216 -81%
AA
16
Ancora Advisors
Ohio
$1K – – –
AC
17
Armistice Capital
New York
– -$2.58M -340,000 Closed
BFM
18
Boothbay Fund Management
New York
– -$566K -74,666 Closed
Wells Fargo
19
Wells Fargo
California
– +$177 +29 New

ALIM Hedge Fund Activity: Q1 2020 in Review

21 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2020, worth a combined $4.59M — down 60% from $11.4M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ALIM and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 7 added.

The largest buyer was David M. Knott, adding an estimated $183K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.58M sold.

  • 21 institutional investors held Alimera Sciences (ALIM) as of Q1 2020, down from 22 in Q4 2019.
  • Funds reported $4.59M of Alimera Sciences stock for Q1 2020, down 60% quarter-over-quarter.
  • 2 funds opened new Alimera Sciences positions in Q1 2020 and 3 closed out, a net change of -1 holder.
  • The largest Alimera Sciences buyer in Q1 2020 was David M. Knott, an estimated $183K added.
  • The largest Alimera Sciences seller in Q1 2020 was Armistice Capital, an estimated $2.58M sold.

Based on aggregated 13F filings for Q1 2020.